NCT04070209
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04070209
Title Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sir Mortimer B. Davis - Jewish General Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Prostate Cancer Centre Calgary Alberta T2V 1P9 Canada Details
Centre of Applied Urology Research Halifax Nova Scotia B3H 2Y9 Canada Details
St. Joseph's Healthcare Hamilton Hamilton Ontario L8N 4A6 Canada Details
Hôpital de Gatineau Gatineau Quebec J8P 7H2 Canada Details
Service d'urologie et Centre de la prostate Longueuil Quebec J4V 2H3 Canada Details
Hôpital Maisonneuve-Rosemont Montreal Quebec H1T 2M4 Canada Details
Centre hospitalier de l'Université de Montréal (CHUM) Montreal Quebec H2X 3E4 Canada Details
Sir Mortimer JGH Montreal Quebec H3T 1E2 Canada Details
L'Hôtel-Dieu de Québec (CHUQ) Québec Quebec G1R 2J6 Canada Details
Hôpital Fleurimont (CHUS) Sherbrooke Quebec J1H 5N4 Canada Details
Centre hospitalier affilié universitaire régional (CHAUR) Trois-Rivières Quebec G8Z 3R9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field